AA amyloidosis: Mount Sinai experience, 1997-2012. (Q38067328)

28 August 2017

AA amyloidosis: Mount Sinai experience, 1997-2012. (English)

1 reference

28 August 2017

1 reference

Daniel Bunker

1

1 reference

PubMed ID

23239212

28 August 2017

Peter Gorevic

series ordinal

2

1 reference

28 August 2017

1 November 2012

1 reference

Mount Sinai Journal of Medicine

28 August 2017

1 reference

28 August 2017

79

1 reference

28 August 2017

749-756

1 reference

28 August 2017

6

1 reference

Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.

28 August 2017

1 reference

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 January 2018

1 reference

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

Systemic amyloidosis in a patient with hypogammaglobulinaemia

21 January 2018

1 reference

Hawthorne and pericardial calcinosis.

21 January 2018

1 reference

Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature

21 January 2018

1 reference

AA-type amyloidosis associated with non-Hodgkin's lymphoma: a case report.

21 January 2018

1 reference

Amyloidosis in association with human immunodeficiency virus infection

21 January 2018

1 reference

Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient.

21 January 2018

1 reference

AA amyloidosis associated with hepatitis B.

21 January 2018

1 reference

AA amyloidosis associated with a mutated serum amyloid A4 protein

21 January 2018

1 reference

Amyloidosis in familial Mediterranean fever. An independent genetically determined character

21 January 2018

1 reference

A survey of phenotype II in familial Mediterranean fever.

21 January 2018

1 reference

Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148.

21 January 2018

1 reference

Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis.

21 January 2018

1 reference

Eprodisate for the treatment of renal disease in AA amyloidosis.

21 January 2018

1 reference

IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system

21 January 2018

1 reference

Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression.

21 January 2018

1 reference

Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis

21 January 2018

1 reference

Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis

21 January 2018

1 reference

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium.

21 January 2018

1 reference

The changing face of AA amyloidosis: a single center experience

21 January 2018

1 reference

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MSJ.21342

1 reference

28 August 2017

1 reference

PubMed ID

23239212